Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Long-Term Anatomical Response to Navigated Micropulse Laser in Chronic Central Serous Chorioretinopathy: A 24-Month Longitudinal Study
Alba Chiara Termite; Antonio Salvelli; Mariapia Laterza; Gabriele Bruno; Giuseppe Pinto; Daniela Bacherini; Arcangelo Clemente; Giacomo Boscia; Clemente Maria Iodice; Giovanni Alessio; Francesco Boscia; Pasquale ViggianoShow moreShow less
1. Department of Translational Biomedicine Neuroscience, University of Bari “Aldo Moro”, Bari, Italy; 2. Department of Neuroscience, Psychology, Drug Research and Child Health, Eye Clinic, University of Florence, Florence, Italy; 3. Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania ‘Luigi Vanvitelli’, Naples, Italy; 4. Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, ItalyShow moreShow less
Early Clinical Adoption and Treatment Patterns of Avacincaptad Pegol for Geographic Atrophy in the USA: An IRIS ® Registry Analysis
Durga Borkar; Jennifer Toth; Siva Balasubramanian; Matthias Stoelzel; Josephine Wolfram; Emily ShortridgeShow moreShow less
1. Department of Ophthalmology, Duke University Eye Center, Durham, USA; 2. Verana Health, San Francisco, USA; 3. Astellas Pharma Inc., Northbrook, USA; 4. Astellas Pharma GmbH, Munich, Germany; 5. Astellas Pharma BV, Leiden, NetherlandsShow moreShow less
Association of Topical Therapy and Surgical Management with Corneal Parameters in Congenital PAX6 -Related Classical Aniridia: a Cross-Sectional Study
Yubo Li; Clara Grünauer-Kloevekorn; Mária Csidey; Annamária Náray; Anita Csorba; Fabian Norbert Fries; Klaudia Kéki-Kovács; Erika Maka; Marta Corton; Kálmán Tory; Eszter Jávorszky; Zoltán Zsolt Nagy; Achim Langenbucher; Márk Bérchegyi; Szilárd Váncsa; Nóra SzentmáryShow moreShow less
1. Department of Ophthalmology, Semmelweis University, Budapest, Hungary; 2. Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Congenital Aniridia Research, Saarland University, Homburg, Germany; 3. Heim Pál National Pediatric Institute, Budapest, Hungary; 4. Department of Genetics and Genomics, Instituto de Investigación Sanitaria−Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS−FJD, UAM), Madrid, Spain; 5. Biomedical Research Networking Center on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain; 6. MTA−SE Lendület Nephrogenetic Laboratory, Hungarian Academy of Sciences, Budapest, Hungary; 7. 1 st Department of Pediatrics, Semmelweis University, Budapest, Hungary; 8. Experimental Ophthalmology, Saarland University, Homburg, Germany; 9. Centre for Translational Medicine, Semmelweis University, Budapest, Hungary; 10. Institute of Pancreatic Diseases, Semmelweis University, Budapest, HungaryShow moreShow less
Early Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in France: A Retrospective Study
Jules Fricker; Lucas Sejournet; Jules Prange; Julien Andre; Remy Calvet; Valentin Rougane; Ségolène Gouze; Maxime Oudard; Ambre Ancel; Alexis Kodjikian; Simona Nicoara; Philippe Desmangles; Thibaud Mathis; Laurent KodjikianShow moreShow less
1. Ophthalmology Department, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; 2. MATEIS Laboratory, UMR-CNRS 5510, INSA, University of Claude, Villeurbanne, France; 3. UMF Iuliu Hațieganu, Cluj-Napoca, Romania; 4. Centre Ophtalmologique Ophtarives, Geneva, SwitzerlandShow moreShow less
Effects and Safety of Grape Skin Enzyme Fermentation Extract for Eye Fatigue and Dry Eye Symptoms: An Exploratory Randomized Controlled Trial
Hoon Kim; Hyun Pil Yang; Yuli Park; Kyongjin ChoShow moreShow less
1. Department of Ophthalmology, Dankook University Hospital, Cheonan, Republic of Korea; 2. Technical R&D Center, Kitto Life Co., Ltd., Pyeongtaek, Republic of KoreaShow moreShow less
Effectiveness of 0.02% and 0.04% Atropine Therapy for Myopia Control in Czech Children: The MARS Trial
Martin Hložánek; Miroslav Dostálek; Rudolf Autrata; Radka Štěpánová; Jana Unar Vinklerová; Jarmila Heissigerová; Pavel Studený; Barbora Čáslavská; Lucie Jeřábková; Nina Zelenayová; Inka Krejčířová; Renáta Brunnerová; Marta Korbasová; Martin KomínekShow moreShow less
1. Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University and University Hospital Motol and Homolka, Prague 5, Czech Republic; 2. Center of Pediatric Ophthalmology, BINOCULAR S.R.O., Litomyšl, Czech Republic; 3. Department of Optometry and Orthoptics, Faculty of Medicine, Masaryk University, Brno, Czech Republic; 4. Department of Pediatric Ophthalmology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic; 5. Center of Excellence CREATIC, Faculty of Medicine, Masaryk University, Brno, Czech Republic; 6. Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; 7. Department of Ophthalmology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech RepublicShow moreShow less
FAQ
How long does Ophthalmology and Therapy take to review a manuscript?
As of 2026-11-19, CrushSCI has 21 complete review records for Ophthalmology and Therapy. The fastest paper went from submission to acceptance in 14 days (Early Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in France: A Retrospective Study, received 2026-09-03, accepted 2026-09-17); the slowest took 150 days. The average is 67.6 days and the median is 56 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
